At 1 and 5 years post-transplant , patient survival was 100 % and 94.7 % in group-1 , 100 % and 95.7 % in group-2 , and 94.7 % and 84 % in group-3 , death-censored graft survival was 100 % and 94.6 % in group-1 , 100 % and 91.3 % in group-2 , and 98.9 % and 94.4 % in group-3 with mean serum creatinine ( mg/dL ) of 1.38 and 1.39 in group-1 , 1.48 and 1.51 in group-2 , and 1.29 and 1.42 and in group-3 .